30 studies found for:    "Spirurida Infections"
Show Display Options
Rank Status Study
1 Completed Evaluation of Antibacterial Soap for Treatment of Lymphedema in a Filariasis-Endemic Area
Conditions: Lymphedema;   Cellulitis
Intervention: Drug: antimicrobial agent in soap
2 Completed Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness
Condition: Onchocerciasis
Interventions: Drug: Rifampin;   Drug: Azithromycin
3 Completed Effect of Albendazole Dose on Treatment of Lymphatic Filariasis
Conditions: Lymphatic Filariasis;   Brugia Malayi Infection
Interventions: Drug: Albendazole;   Drug: Diethylcarbamazine
4 Recruiting A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa Loa Infection
Condition: Loiasis
Interventions: Drug: Reslizumab;   Drug: Diethylcarbamazine
5 Completed Effect of Albendazole Dose on Clearance of Filarial Worms
Condition: Lymphatic Filariasis
Interventions: Drug: Albendazole;   Drug: Ivermectin
6 Withdrawn Pediatric Pharmacokinetics And Safety Study Of Moxidectin
Condition: Onchocerciasis
Intervention: Drug: moxidectin
7 Completed Post-Treatment Side Effects of Ivermectin or DEC for Loa Loa Infection
Condition: Loa Loa
Interventions: Drug: Diethylcarbamazine;   Drug: Ivermectin
8 Completed Research for Elim of Filariasis
Condition: W. Bancrofti Filariasis
Intervention:
9 Recruiting Promoting Consistent Shoe Use Among Children At High Risk for Podoconiosis
Conditions: Podoconiosis;   Non-Filarial Elephantiasis
Intervention:
10 Recruiting Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis
Conditions: Lymphatic Filariasis;   Soil Transmitted Helminth Infections
Intervention: Drug: Albendazole and diethylcarbamazine
11 Not yet recruiting Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana
Condition: Onchocerciasis
Interventions: Drug: IVM plus ALB;   Drug: IVM
12 Completed Research for Elimination of Lymphatic Filariasis (ICIDR)
Condition: Lymphatic Filariasis
Intervention:
13 Recruiting Host Response to Infection and Treatment in Filarial Diseases
Conditions: Filariasis;   Helminthiasis;   Loiasis;   Mansonelliasis;   Onchocerciasis
Intervention:
14 Recruiting Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Liberia
Conditions: Lymphatic Filariasis;   Onchocerciasis;   Soil Transmitted Helminth (STH) Infections
Intervention: Drug: Annual versus Semiannual Albendazole plus Ivermectin Mass Drug Administration
15 Recruiting Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa
Condition: Lymphatic Filariasis
Interventions: Drug: Diethylcarbamazine;   Drug: Albendazole;   Drug: Ivermectin
16 Not yet recruiting Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast)
Conditions: Lymphatic Filariasis;   Onchocerciasis;   Soil Transmitted Helminth (STH) Infections
Intervention: Drug: Annual versus Semiannual Albendazole plus Ivermectin MDA
17 Not yet recruiting Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis
Conditions: Trachoma;   Lymphatic Filariasis
Interventions: Drug: azithromycin;   Drug: ivermectin;   Drug: albendazole;   Drug: placebo
18 Completed Medical Implications of Coinfection With Malaria and Filariasis Parasites
Conditions: Malaria;   Filariasis
Intervention:
19 Completed Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection
Condition: Onchocerciasis
Interventions: Drug: 2 mg moxidectin;   Drug: ivermectin 150 mcg/kg;   Drug: 4 mg moxidectin;   Drug: 8 mg moxidectin
20 Completed Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis Elimination
Conditions: Parasitic Diseases;   Bacterial Diseases
Intervention: Drug: triple co administration at once of the combination of Albendazole + ivermectin + azithromycin

Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results
Indicates status has not been verified in more than two years